These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38428661)

  • 1. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
    Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
    J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total flavonoids of Taraxacum mongolicum inhibit non-small cell lung cancer by regulating immune function.
    Kang L; Miao MS; Song YG; Fang XY; Zhang J; Zhang YN; Miao JX
    J Ethnopharmacol; 2021 Dec; 281():114514. PubMed ID: 34384846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
    Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
    BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.
    Yan F; Wang X; Xie Y; Liu X; Yu L; Wang P; Li T; Wang S; Li W; Yang Z
    Phytomedicine; 2021 Oct; 91():153722. PubMed ID: 34488188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
    Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
    Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation 
in NSCLC Development].
    Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
    Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
    Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
    Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
    Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
    Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
    Gong B; Wang L; Zhang H; Wang Q; Li W
    Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
    Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
    Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
    J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.